Wolfgang Maier Selected Research

Nortriptyline (Aventyl)

1/2019	Trajectories of Suicidal Ideation During 12 Weeks of Escitalopram or Nortriptyline Antidepressant Treatment Among 811 Patients With Major Depressive Disorder.
1/2019	Effect of antidepressant switching between nortriptyline and escitalopram after a failed first antidepressant treatment among patients with major depressive disorder.
10/2018	Genetic disposition to inflammation and response to antidepressants in major depressive disorder.
1/2016	Combining clinical variables to optimize prediction of antidepressant treatment outcomes.
12/2014	An inflammatory biomarker as a differential predictor of outcome of depression treatment with escitalopram and nortriptyline.
12/2012	Self-report and clinician-rated measures of depression severity: can one replace the other?
10/2012	Non-random dropout and the relative efficacy of escitalopram and nortriptyline in treating major depressive disorder.
4/2011	Changes in body weight during pharmacological treatment of depression.
12/2010	Stressful life events, cognitive symptoms of depression and response to antidepressants in GENDEP.
6/2010	History of suicide attempts among patients with depression in the GENDEP project.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Wolfgang Maier Research Topics

Disease

73	Schizophrenia (Dementia Praecox) 04/2022 - 04/2002
62	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 02/2002
43	Dementia (Dementias) 01/2022 - 01/2007
34	Cognitive Dysfunction 01/2022 - 05/2005
24	Major Depressive Disorder (Major Depressive Disorders) 04/2022 - 01/2005
10	Psychotic Disorders (Schizoaffective Disorder) 12/2019 - 04/2004
9	Bipolar Disorder (Manic Depressive Psychosis) 01/2021 - 04/2002
8	Depressive Disorder (Melancholia) 01/2019 - 06/2006
7	Mood Disorders (Mood Disorder) 04/2010 - 07/2002
6	Genetic Risk Score 01/2021 - 01/2016
6	Neoplasms (Cancer) 05/2017 - 05/2004
6	Prodromal Symptoms 01/2017 - 04/2004
6	Mental Disorders (Mental Disorder) 01/2014 - 03/2006
6	Panic Disorder (Panic Attack) 10/2012 - 12/2000
5	Chronic Disease (Chronic Diseases) 01/2022 - 08/2014
5	Substance-Related Disorders (Drug Abuse) 03/2016 - 06/2004
4	Disease Progression 01/2022 - 02/2015
4	Drug-Related Side Effects and Adverse Reactions 11/2021 - 09/2009
4	Inflammation (Inflammations) 01/2019 - 12/2014
4	Stroke (Strokes) 01/2019 - 01/2012
4	Tobacco Use Disorder (Nicotine Dependence) 03/2016 - 12/2005
4	Anxiety Disorders (Anxiety Disorder) 08/2015 - 06/2008
4	Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive) 01/2014 - 03/2004
4	Weight Gain 07/2011 - 03/2008
3	Infections 06/2022 - 01/2016
3	Neurobehavioral Manifestations 01/2018 - 03/2009
3	Atrophy 10/2014 - 01/2011
3	Paraganglioma (Paragangliomas) 06/2014 - 03/2005
3	Alcoholism (Alcohol Abuse) 01/2012 - 12/2008
2	Pain (Aches) 12/2021 - 01/2018
2	Clinical Deterioration 01/2020 - 11/2007
2	Neurodegenerative Diseases (Neurodegenerative Disease) 08/2018 - 01/2011
2	Obesity 01/2017 - 11/2009
2	Wounds and Injuries (Trauma) 03/2016 - 09/2014
2	Deafness (Deaf Mutism) 09/2015 - 01/2009
2	Autistic Disorder (Autism) 08/2014 - 11/2008
2	Unilateral Hearing Loss 09/2013 - 08/2008

Drug/Important Bio-Agent (IBA)

24	Biomarkers (Surrogate Marker)IBA 01/2022 - 03/2006
23	Antidepressive Agents (Antidepressants)IBA 04/2022 - 09/2003
19	Antipsychotic Agents (Antipsychotics)IBA 12/2019 - 08/2005
18	Amyloid (Amyloid Fibrils)IBA 01/2022 - 12/2004
17	Apolipoproteins E (ApoE)IBA 01/2022 - 01/2004
15	Biological ProductsIBA 01/2021 - 10/2002
15	Escitalopram FDA Link 01/2019 - 03/2009
15	Nortriptyline (Aventyl)FDA LinkGeneric 01/2019 - 03/2009
13	Proteins (Proteins, Gene)FDA Link 01/2022 - 08/2003
12	Pharmaceutical PreparationsIBA 12/2021 - 12/2003
10	CholesterolIBA 01/2019 - 09/2005
9	ApolipoproteinsIBA 01/2021 - 08/2003
9	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 12/2005
7	Risperidone (Risperdal Consta)FDA LinkGeneric 02/2014 - 11/2007
6	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2016 - 07/2005
5	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2016 - 10/2007
5	Transcription Factor 4IBA 07/2015 - 01/2011
5	Amyloid beta-PeptidesIBA 12/2014 - 07/2003
5	Serotonin (5 Hydroxytryptamine)IBA 01/2012 - 01/2008
5	DysbindinIBA 05/2010 - 01/2003
4	Indicators and Reagents (Reagents)IBA 01/2019 - 04/2002
4	Anticonvulsants (Antiepileptic Drugs)IBA 01/2018 - 12/2003
4	Apolipoprotein E4IBA 10/2016 - 01/2004
4	Oxytocin (Pitocin)FDA LinkGeneric 08/2015 - 04/2010
4	Haloperidol (Haldol)FDA LinkGeneric 02/2014 - 11/2007
4	Neurotransmitter Agents (Neurotransmitter)IBA 01/2012 - 04/2004
3	Glutamate Receptors (Glutamate Receptor)IBA 01/2022 - 03/2004
3	EnzymesIBA 01/2020 - 10/2004
3	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 01/2019 - 12/2010
3	C-Reactive ProteinIBA 10/2018 - 12/2014
3	Glutamic Acid (Glutamate)FDA Link 01/2017 - 10/2008
3	Peptides (Polypeptides)IBA 03/2016 - 01/2011
3	Succinate Dehydrogenase (Fumarate Reductase)IBA 06/2014 - 03/2005
3	5-HT3 Serotonin Receptors (5 HT3 Receptor)IBA 01/2014 - 11/2009
3	NeuropeptidesIBA 10/2013 - 04/2010
3	Nicotine FDA Link 08/2013 - 12/2005
3	Dexamethasone (Maxidex)FDA LinkGeneric 02/2013 - 05/2010
3	N-Methyl-3,4-methylenedioxyamphetamine (MDMA)IBA 01/2013 - 05/2006
3	N-acetylaspartate (N-acetyl aspartate)IBA 01/2013 - 01/2005
3	24-hydroxycholesterolIBA 08/2010 - 05/2006
3	Neuregulin-1 (Neuregulin 1)IBA 03/2009 - 01/2006
3	5-HT2A Serotonin Receptor (5 HT2A Receptor)IBA 03/2009 - 12/2005
3	Cathepsin DIBA 06/2004 - 02/2002
2	Amino Acids FDA Link 01/2020 - 10/2012
2	LipidsIBA 09/2019 - 01/2019
2	Hormones (Hormone)IBA 01/2019 - 02/2013
2	Tricyclic Antidepressive Agents (Tricyclic Antidepressants)IBA 01/2019 - 04/2011
2	Testosterone (Sustanon)FDA Link 01/2019 - 12/2008
2	ProlactinIBA 01/2019 - 12/2008
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2018 - 04/2007
2	Proton Pump InhibitorsIBA 04/2016 - 08/2015
2	NucleotidesIBA 07/2015 - 02/2008
2	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 09/2013 - 05/2012
2	GlucocorticoidsIBA 02/2013 - 10/2007
2	Glucose (Dextrose)FDA LinkGeneric 01/2013 - 04/2012

Therapy/Procedure

13	Therapeutics 01/2022 - 04/2004
8	Activities of Daily Living (ADL) 01/2022 - 11/2012
4	Institutionalization (Institutionalized Persons) 01/2022 - 02/2012
4	Electrodes (Electrode) 09/2014 - 01/2009
4	Cochlear Implantation 09/2013 - 01/2009
4	Secondary Prevention 02/2011 - 04/2004
3	Home Nursing (Nursing, Home) 01/2015 - 01/2012
2	Patient Care 04/2016 - 01/2013